What is Zenas BioPharma, Inc. Common Stock's Market Cap?

Zenas BioPharma, Inc. Common Stock's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.

What is Zenas BioPharma, Inc. Common Stock's Enterprise Value?

Zenas BioPharma, Inc. Common Stock's Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is Zenas BioPharma, Inc. Common Stock's Price / Sales?

Zenas BioPharma, Inc. Common Stock's Price / Sales is 2153.4×, based on as-reported figures from SEC (XBRL) filings.

What is Zenas BioPharma, Inc. Common Stock's EV / Revenue?

Zenas BioPharma, Inc. Common Stock's EV / Revenue is 1588.9×, based on as-reported figures from SEC (XBRL) filings.

What is Zenas BioPharma, Inc. Common Stock's EV / EBITDA?

Zenas BioPharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Zenas BioPharma, Inc. Common Stock's Revenue (TTM)?

Zenas BioPharma, Inc. Common Stock's Revenue (TTM) is $1.0M, based on as-reported figures from SEC (XBRL) filings.

What is Zenas BioPharma, Inc. Common Stock's Net Income (TTM)?

Zenas BioPharma, Inc. Common Stock's Net Income (TTM) is -$484.4M, based on as-reported figures from SEC (XBRL) filings.

What is Zenas BioPharma, Inc. Common Stock's EBITDA?

Zenas BioPharma, Inc. Common Stock's EBITDA is -$475.5M, based on as-reported figures from SEC (XBRL) filings.

What is Zenas BioPharma, Inc. Common Stock's Diluted EPS (TTM)?

Zenas BioPharma, Inc. Common Stock's Diluted EPS (TTM) is -7.43, based on as-reported figures from SEC (XBRL) filings.

What is Zenas BioPharma, Inc. Common Stock's EBITDA Margin?

Zenas BioPharma, Inc. Common Stock's EBITDA Margin is -47554.2%, based on as-reported figures from SEC (XBRL) filings.

Zenas BioPharma, Inc. Common Stock (ZBIO) Financial Statements

Zenas BioPharma, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01J1MG9F4

XNAS · usd

33.04▼ 0.01 (-0.03%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close33.05

Day's Range32.31 – 33.84

52-Week Range13.50 – 44.60

Volume440.8K

Avg Volume663.2K

Share Statistics

Shares Outstanding

Employees167

ExchangeXNAS

Listed2024-09-13

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Zenas BioPharma, Inc. Common Stock (ZBIO)

What is Zenas BioPharma, Inc. Common Stock's Market Cap?: Zenas BioPharma, Inc. Common Stock's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Zenas BioPharma, Inc. Common Stock's Enterprise Value?: Zenas BioPharma, Inc. Common Stock's Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Zenas BioPharma, Inc. Common Stock's Price / Sales?: Zenas BioPharma, Inc. Common Stock's Price / Sales is 2153.4×, based on as-reported figures from SEC (XBRL) filings.
What is Zenas BioPharma, Inc. Common Stock's EV / Revenue?: Zenas BioPharma, Inc. Common Stock's EV / Revenue is 1588.9×, based on as-reported figures from SEC (XBRL) filings.
What is Zenas BioPharma, Inc. Common Stock's EV / EBITDA?: Zenas BioPharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Zenas BioPharma, Inc. Common Stock's Revenue (TTM)?: Zenas BioPharma, Inc. Common Stock's Revenue (TTM) is $1.0M, based on as-reported figures from SEC (XBRL) filings.
What is Zenas BioPharma, Inc. Common Stock's Net Income (TTM)?: Zenas BioPharma, Inc. Common Stock's Net Income (TTM) is -$484.4M, based on as-reported figures from SEC (XBRL) filings.
What is Zenas BioPharma, Inc. Common Stock's EBITDA?: Zenas BioPharma, Inc. Common Stock's EBITDA is -$475.5M, based on as-reported figures from SEC (XBRL) filings.
What is Zenas BioPharma, Inc. Common Stock's Diluted EPS (TTM)?: Zenas BioPharma, Inc. Common Stock's Diluted EPS (TTM) is -7.43, based on as-reported figures from SEC (XBRL) filings.
What is Zenas BioPharma, Inc. Common Stock's EBITDA Margin?: Zenas BioPharma, Inc. Common Stock's EBITDA Margin is -47554.2%, based on as-reported figures from SEC (XBRL) filings.